As of 2026-04-05, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (110.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -261.2%.
The range of the Relative Valuation is (101.22) - (124.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 27.4x | 24.3x |
| Forward P/E multiples | 21.0x - 26.1x | 21.9x |
| Fair Price | (101.22) - (124.92) | (110.39) |
| Upside | -247.8% - -282.4% | -261.2% |
| Date | P/E |